Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 17Unknown 3Active not recruiting 3Recruiting 2Terminated 1Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 46Breast Neoplasms 46Colorectal Neoplasms 27Prostatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 21Leukemia, Myeloid, Acute 20Glioblastoma 19Melanoma 17Lung Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 16Glioma 14Stomach Neoplasms 13Ovarian Neoplasms 13Brain Neoplasms 13Carcinoma, Hepatocellular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Triple Negative Breast Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Carcinoma, Renal Cell 10Lymphoma 9Uterine Cervical Neoplasms 7Sarcoma 7Rectal Neoplasms 7Leukemia 7Hematologic Neoplasms 7Esophageal Neoplasms 7Colonic Neoplasms 7

Interventions

Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Advanced Solid Malignancies × Clear all
NCT06388902 2025-11-21

A Phase I Study of BR115 for Injection Alone in Subjects With Advanced Solid Malignancies

BioRay Pharmaceutical Co., Ltd.

Phase 1 Suspended
120 enrolled

Advanced Solid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡